Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, ...

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton, Dickinson and Company (BDX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

This was the stock's second consecutive day of losses.

BECTON, DICKINSON ($BDX) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of $3.35 per share, beating estimates of $3.31 by $0.04 ...

The stock's rise snapped a four-day losing streak.

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Barclays on June 3, 2025. The analyst firm set a price target for $241.00 expecting BDX to rise to within 12 months (a ...

In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against the other oversold stocks. Due to the uncertainty surrounding the tariff news ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...